Study to Evaluate the Efficacy of a Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

Click the JOIN button if you think you might be eligible for this study. Company Please complete the form below with your contact information. By completing this form, you are providing your permission (consent) for research professionals to contact you about active or future studies and health research news. Email Address * First Name * Last Name